Genmab A (GMAB) Cash & Equivalents (2023 - 2026)
Genmab A's Cash & Equivalents came in at $1.5 billion for the quarter ended Jun 30, 2026, down 1.2% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Cash & Equivalents (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A's Cash & Equivalents was $1.72 billion, up 24.3% from the prior year.
- Cash & Equivalents carries a five-year compound annual growth rate of 15.3% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash & Equivalents was $1.38 billion in the year ended Dec 31, 2024 (-37.4%), $2.2 billion in the year ended Dec 31, 2023 (+55.3%), $1.42 billion in the year ended Dec 31, 2022 (+40.2%) and $1.01 billion in the year ended Dec 31, 2021 (+20.0%).
- The five-year range for quarterly Cash & Equivalents is $367.49 million (the quarter ended Sep 30, 2025) to $1.72 billion (the quarter ended Dec 31, 2025).
- Year-over-year, Cash & Equivalents increased in two of the last four quarters, with growth averaging 24.9%.
- The fastest year-over-year change in Cash & Equivalents over five years came in the quarter ended Jun 30, 2025 (growth of 108.4%), and the weakest in the quarter ended Sep 30, 2021 (a decline of 88.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Genmab A | 2.87 Bn | -2.51 Bn | 1.07 Bn | 1.50 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Bn |
| Mar 31, 2026 | 1.52 Bn |
| Dec 31, 2025 | 1.72 Bn |
| Sep 30, 2025 | 367.49 Mn |
| Jun 30, 2025 | 1.30 Bn |
| Mar 31, 2025 | 1.62 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Jun 30, 2024 | 622.00 Mn |
| Dec 31, 2023 | 2.20 Bn |
| Jan 1, 2023 | 1.42 Bn |
API Access
Genmab A Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();